Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions [case report].

Duan, Lucy; Renzi, Samuele; Weidman, Danielle; Waespe, Nicolas; Chami, Rose; Manson, David; Cada, Michaela; Carcao, Manuel (2020). Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions [case report]. Journal of pediatric hematology, oncology, 42(1), pp. 74-78. Lippincott Williams & Wilkins 10.1097/MPH.0000000000001268

Text Duan_JPediatrHematolOncol_2020.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (357kB) | Request a copy

Kaposiform hemangioendothelioma (KHE) is a rare infiltrative vascular tumor that may be associated with Kasabach-Merritt Phenomenon (KMP), which is a consumptive coagulopathy with potentially life-threatening thrombocytopenia. Management of KHE and KMP is challenging, and currently, there are no standardized validated treatment protocols. Mammalian target of rapamycin inhibitors have been shown to be effective in the treatment of KHE. We describe a term male who presented as a diagnostic dilemma with life-threatening pleural and pericardial effusions and severe thrombocytopenia. After extensive work-up the etiology for his condition was determined to be KHE with KMP. The patient was commenced on sirolimus and responded well to therapy with resolution of KMP.

Interest & Impact

Downloads

268 since deposited on 28 Aug 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item